Submaximal CPET provides valuable prognostic information in cardiac amyloidosis and may serve as an alternative to the 6-min walk test.
Does submaximal cardiopulmonary exercise testing (CPET) provide prognostic value and serve as an alternative to the 6-min walk test in patients with cardiac amyloidosis?
Submaximal cardiopulmonary exercise testing (CPET) is being explored for its prognostic value and as an alternative to the 6-min walk test in cardiac amyloidosis.
Absolute Event Rate: 0% vs 0%
Background: This study assessed the prognostic value of submaximal cardiopulmonary exercise testing (CPET) in cardiac amyloidosis and explored CPET as an alternative to the 6-min walk test (6MWT).
Willixhofer et al. (Mon,) reported a other. Submaximal CPET provides valuable prognostic information in cardiac amyloidosis and may serve as an alternative to the 6-min walk test.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: